Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
63%
Total
Publications
127
Total Open
Publications
80
Total
Citations
6.5K
Open Access
Percentage
63%
Total
Publications
127
Total Open
Publications
80
Total
Citations
6.5K
Breakdown
Publisher Open
14%
Both
25%
Other Platform Open
24%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
22
Hybrid 8%
4
No Guarantees 47%
23
Other Platform Open
Domain 76%
48
Other Internet 25%
16
Institution 6%
4
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 49 |
DOI | Other Internet | 16 |
Europe PMC | Domain | 2 |
University of Michigan - Deep Blue | Institution | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
ORA - Oxford University Research Archive | Institution | 1 |